Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
immune sensor-enhanced CAR-T cells
- Development stage
- Preclinical
- Lead developer
- Edity Therapeutics
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Gene Therapies
- Administration
- Intravenous
01
Overview
Edity Therapeutics' immune sensor-enhanced CAR-T cells are a next-generation cell therapy platform designed to treat solid tumors by overcoming the immunosuppressive tumor microenvironment (TME). The platform utilizes AI-guided computational optimization to integrate engineered innate immune sensors, specifically derived from the STING (Stimulator of Interferon Genes) and MAVS (Mitochondrial Antiviral-Signaling Protein) pathways, into CAR-T cells. These sensors are fused to a navigator domain that ensures their activation is strictly dependent on CAR signaling upon antigen engagement at the tumor site. Once activated, these sensor modules drive the production of Type I interferons and pro-inflammatory cytokines, effectively converting an immune-cold TME into an inflamed milieu. This localized immune provocation is intended to induce robust systemic anti-tumor immunity while minimizing peripheral adverse effects.
- Other names
- AI-designed immune sensor-enhanced CAR-T cells
02
Targets
STING (Stimulator of interferon genes protein)MAVS (Mitochondrial antiviral-signaling protein)ERBB2 (Erb-b2 receptor tyrosine kinase 2)
Beyond the preview
Go deeper on immune sensor-enhanced CAR-T cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on immune sensor-enhanced CAR-T cells.